RYAN POLLACK: Open Payments
NPI 1740875053 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,797 in 47 payments from 9 companies in 2025. Trend: 2023 $1,543 · 2024 $665 · 2025 $1,797
Food & beverage: $1,141Travel & lodging: $655
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 26 | $1,264 |
| GlaxoSmithKline, LLC. | 10 | $158 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $114 |
| GENZYME CORPORATION | 2 | $65 |
| AERIN MEDICAL INC. | 1 | $57 |
| Optinose US, Inc. | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Phadia US Inc. | 1 | $19 |
Products named: NUVENT, NUCALA, NEFFY, DUPIXENT, VIVAER STYLUS, Xhance, STEALTHSTATION S8 PLATFORM, TEZSPIRE.
Industry payments across FL — which companies pay providers there.
